Evaluating LRRK2 genetic variants with unclear pathogenicity

by Refai F.S., Ng S.H., Tan E.-K.
Published 2018

Clinically reported heterozygous mutations in the PINK1 kinase domain exert a gene dosage effect

by Tan, E.-K., Refai, F.S., Siddique, M., Yap, K., Ho, P., Fook-Chong, S., Zhao, Y.
Published 2014

Mutant PINK1 upregulates tyrosine hydroxylase and dopamine levels, leading to vulnerability of dopaminergic neurons

by Zhou, Z.D., Refai, F.S., Xie, S.P., Ng, S.H., Chan, C.H.S., Ho, P.G.H., Zhang, X.D., Lim, T.M., Tan, E.K.
Published 2014